Nutex Health Inc. Common Stock (NUTX) is a publicly traded Healthcare sector company. As of September 11, 2026, NUTX trades at $195.11 with a market cap of $1.35B and a P/E ratio of 17.57. NUTX moved -1.38% today. Year to date, NUTX is +31.72%; over the trailing twelve months it is +134.50%. Its 52-week range spans $36.05 to $204.00. Analyst consensus is strong buy with an average price target of $278.33. Rallies surfaces NUTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NUTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $195.11 |
| Market Cap | $1.35B |
| P/E Ratio | 17.57 |
| EPS | $11.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $204.00 |
| 52-Week Low | $36.05 |
| Volume | 78.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $875.26M |
| Net Income | $180.36M |
| Gross Margin | 50.76% |
3 analysts cover NUTX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $278.33.